Haorui Pharma-Chem Inc.

About Haorui Products Technology Contact
 
API Index
 
A
Adapalene
Alfuzosin HCl
  Altrenogest 
  Amifostine
  5-Aminolevulinic acid 
  Amisulpride
  Amlexanox
  Amorolfine HCl   
  Anastrozole 
  Ascomycin (FK520)
  Atracurium besylate
  Azelastine HCl
  Aztreonam
  B
  Benidipine HCl 
  Bicalutamide
  Brimonidine tartrate
  C
  Camptothecin
  Candesartan cilexetil 
  Capecitabine
  D
  Daptomycin
  Dasatinib
  Desogestrel
  Dexrazoxane 
  Dirithromycin
  Dipeptiven
  Docetaxel
  Dofetilide
  Dolasetron mesylate
  Donepezil HCl
  Doramectin
  Doxazosin mesylate
  Drospirenone
  E
  Entecavir
  Epalrestat
  Eplerenone
  Epinastine HCl
  Eplerenone
  Erlotinib HCl
  Erythromycin ethylsuccinate
  Escitalopram oxalate
  Estradiol
  Estradiol Benzoate
  Estriol
  Ethinyl Estradiol
  Everolimus
  Exemestane
  Everolimus
  F
  Fipronil
  Fludarabine phosphate
  Flumazenil
  Fluvastatin sodium
  G
  Gefitinib
  Gemcitabine HCl
  Gestodene
  Gestrinone
  Glimepiride
  Granisetron HCl
  H
  10-hydroxycamptothecin
  I
  Ibandronate sodium
  Ibutilide fumarate
  Imatinib mesylate
  Imipenem + Cilastatin sodium 
  Irbesartan 
  Irinotecan HCl 
  L
  Latanoprost
  Lenalidomide
  Letrozole
  Levetiracetam
  Levofloxacin 
  Levonorgestrel 
  Linezolid
  Lymecycline
  Lynoestrenol 
  M
  Maraviroc
  Melengestrol acetate
  Memantine HCl   
  Meropenem  
  Mestranol
  Methazolamide
  Mifepristone 
  Midazolam
  Miglitol 
  Mitoxantrone HCl
  Mizolastine HCl 
  Mofegiline HCl
  Mosapride citrate
  Moxidectin
  Mupirocin
  N
  N(2)-L-alanyl-L-glutamine
  Nandrolone phenylpropionate
  Nabumetone
  Natamycin
  Nebivolol
  Nedaplatin
  Nilutamide
  Norelgestromin 
  Norgestimate
  O
  Olanzapine
  Orlistat 
  Oxaliplatin 
  P
  Paclitaxel
  Palonosetron
  Pamidronate disodium
  Pemetrexed disodium
  Pemirolast potassium
  Polymyxin B sulfate
  Pramipexole 2HCl 
  Pranlukast hydrate
  R
  Racecadotril
  Rilmenidine
  Ramosetron
  Ranolazine
  Rapamycin (Sirolimus) 
  Rebamipide 
  Retigabine
  Rifaximine
  Rilmenidine  
  Riluzole 
  Risedronate sodium
  Rizatriptan benzoate
  Ropinirole
  Ropivacaine HCL
  S
  Sirolimus (Rapamycin) 
  Sorafenib tosylate
  Sunitinib malate
  T
  Tacrolimus (FK506) 
  Tamsulosin HCl 
  Tazobactam+Piperacillin 
  Teicoplanin
  Telmisartan 
  Temozolomide 
  Terazosin HCl
  Tibolone
  Tigecycline
  Topotecan HCl
  Travoprost
  Trenbolone Acetate
  Trimegestone
  Tropisetron HCL
  V
  Valsartan 
  Valrubicin 
  Vancomycin HCl
  Vecuronium bromide
  Venlafaxine HCl   
  Vinorelbine tartrate
  Voglibose
  Voriconazole
  Z
  Zanamivir
  Zoledronic acid
  Zolmitriptan
  Zonisamide
Haorui supplies Amifostine API (Active Pharmaceutical Ingredient) to pharmaceutical industry.  Haorui's Amifostine API is produced by FDA approved cGMP facilities, we supply Amifostine API from small R&D to large commercial quantity. For product and supply details please contact us.
Amifostine Patents 1

Amifostine Clinical Trials 1       Amifostine Clinical Trials 2

Amifostine Patents 1               Amifostine Patents 2                 Amifostine Patents 3
Amifostine Patents 4               Amifostine Patents 5
 
1 7,371,871 Inhibitors of glutaminyl cyclase
2 7,368,440 Methods for the administration of amifostine and related compounds
3 7,361,341 Methods of treating cancer using antibodies that immunospecifically bind to trail receptors
4 7,358,274 Methods for treating or preventing cancer using Benzopyranone Compounds
5 7,358,272 Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4 acetylaminoisoindoline 1,3-dione
6 7,355,008 Identification and engineering of antibodies with variant Fc regions and methods of using same
7 7,354,948 Methods for treatment of chronic uveitis using cyclopropyl-n-{2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)eth- yl]-3-oxoisoindoline-4-yl}carboxamide
8 7,354,584 Recombinant IL-9 antibodies
9 7,351,739 Bioactive compounds and methods of uses thereof
10 7,351,729 JNK inhibitors for use in combination therapy for treating or managing proliferative disorders and cancers
11 7,348,003 Methods of treating cancer using antibodies that immunospecifically bind to TRAIL receptors
12 7,342,046 Gossypol co-crystals and the use thereof
13 7,342,017 1,2,5-Thiadiazol-3-yl-piperazine therapeutic agents useful for treating pain, depression and anxiety
14 7,335,769 Preparation of hymenialdsine derivatives and use thereof
15 7,335,649 Thrombopoietin mimetics
16 7,335,382 Compositions and methods for the treatment and prevention of cancer
17 7,332,481 Thrombopoietin mimetics
18 7,329,721 Maleamic acid polymer derivatives and their bioconjugates
19 7,326,685 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof
20 7,323,479 Methods for treatment and management of brain cancer using 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-methylisoindoline
21 7,320,992 Substituted 2,3-dihydro-1h-isoindol-1-one derivatives and methods of use
22 7,314,959 Amino thiol compounds and compositions for use in conjunction with cancer therapy
23 7,314,886 Tetrahydropyrano-indole derivatives
24 7,312,301 Methods for the formation of hydrogels using thiosulfonate compositions and uses thereof
25 7,312,241 Diphenylethylene compounds and uses thereof
26 7,311,924 Compositions and methods for treating cancer
27 7,307,088 Substituted anthranilic amide derivatives and methods of use
28 7,304,086 Inhibitors of glutaminyl cyclase
29 7,291,461 Methods for identifying small molecules that modulate premature translation termination and nonsense mRNA decay
30 7,285,542 Hyperthermic inducible expression vectors for gene therapy and methods of use thereof
31 7,282,484 Anti-tumor agents
32 7,282,221 Antiviral product, use and formulation thereof
33 7,279,493 Therapeutic agents useful for treating pain
34 7,276,506 Immunosuppressive effects of pteridine derivatives
35 7,271,245 Methods and compositions for inhibition of metastasis
36 7,271,001 Method for mitochondrial targeting of p53
37 7,262,194 Therapeutic agents useful for treating pain
38 7,262,182 Sulfonylethyl phosphorodiamidates
39 7,259,266 Benzopyran compounds useful for treating inflammatory conditions
40 7,259,167 Antimalarial and antiproliferative pharmacophore models, novel tryptanthrin compounds having increased solubility, and methods of making and using thereof
41 7,259,138 Anti-tumor agents
42 7,256,210 7-amido-isoindolyl compounds and methods of their use
43 7,256,193 Therapeutic agents useful for treating pain
44 7,247,714 Protection against oxidative stress and inflammation by a cytoprotective response element
45 7,247,646 Benzopyranone compounds, compositions thereof, and methods of treatment therewith
46 7,244,759 Isoindoline compounds and methods of making and using the same
47 7,238,679 Heterocycles and uses thereof
48 7,235,583 Fatty acid-anticancer conjugates and uses thereof
49 7,230,012 Pharmaceutical compositions and dosage forms of thalidomide
50 7,229,960 Methods and compositions for inhibiting GRB7

 

 

Haorui - Your Partner to Pharmaceutical Success - Copy Right Reserved